Wednesday Dec 30 | EMaxHealth
Worrisome first case of highly drug-resistant TB in US
As part of a six month investigation of global drug resistance, Associated Press came across the first case of highly drug-resistant TB in the US.
Highly drug-resistant tuberculosis treatment - time to push the TB vaccine?
The Associated Press is reporting the first known case of a highly drug resistant, contagious, and virulent strain of tuberculosis .
Rifampin - The Antibiotic That Tuberculosis Thrives On
When you register, comments on your articles and replies to your comments appear here.
Researchers Identify Tuberculosis Strain That Thrives on Antibiotic
Scientists have identified a strain of antibiotic-resistant tuberculosis that thrives in the presence of rifampin, a front-line drug in the treatment of tuberculosis.
Cleveland Clinic Journal of Medicine
ADDRESS: Nizar N. Zein, MD, Department of Gastroenterology and Hepatology, A30, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail zeinn{at}ccf.org . Abstract Cutaneous changes may be the first clue that a patient has liver disease.
Current Guidelines Need to Be Changed for Both First-line Treatment...
Every year nearly ten million people develop tuberculosis , a contagious infection, usually of the lungs.
Laboratory Sciences: Experimental Ocular Tuberculosis in Guinea Pigs
Objective To develop an animal model of intraocular tuberculosis with features of pulmonary TB and extrapulmonary dissemination to the eye.
Analysis of TB treatment studies identifies gaps in guidelines
International guidelines for treating tuberculosis are due for specific improvements, according to two research papers published this week in the open access journal PLoS Medicine .
What You Need to Know About the Super Antibiotic Called Rifampin
Rifampin is often used in conjunction with other drugs in the treatment of tuberculosis.
Molecular detection of rifampin and isoniazid resistance to guide...
Drug-resistant tuberculosis is considered a real threat to the achievement of TB control.
CYP2B6 G516T polymorphism but not rifampin coadministration...
CYP2B6 G516T polymorphism but not rifampin coadministration influences steady-state pharmacokinetics of efavirenz in human immunodeficiency virus-infected patients in South India.
Also on Topix